News pages
2005 July August September October November December 2006 January February March April May June YTD

Recent reports in Science and Medicine for April 2006

Some of these links are very transient and may expire within days of posting. Some may require prior registration. Check-in and view frequently to avoid missing great news items. I welcome any suggested articles. (email link). An "*" indicates a recommended article.

::::::::::            April 28             
  :::::::::  Weekend Reading - Basic Science and general interest articles  ::::::::: 
  1. FDA
  2. *  Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. [The Lancet (limited access). Reviews: ScienceNOW, Science Daily, New Scientist]
  3. Effect of a US National Institutes of Health programme of clinical trials on public health and costs. Lancet. 2006 Apr 22;367(9519):1319-27. [Pubmed]
  4. Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial. Intl J Obesity Online publication 18 April 2006. [Eurekalert]
  5. Haplotype Insufficiency for Suppressor of Cytokine Signaling-2 Enhances Intestinal Growth and Promotes Polyp Formation in Growth Hormone-Transgenic Mice. Endocrinology 2006 147: 1632-1641.
  6. Obesity, Disordered Eating, and Eating Disorders in a Longitudinal Study of Adolescents: How Do Dieters Fare 5 Years Later? J Am Dietetic Ass. 2006. [News] [Eurekalert]
::::::::::            April 27            ::::::::::      
  1. * An Inducible Mouse Model of Melanoma Expressing a Defined Tumor Antigen. Cancer Res 2006 66: 3278-3286.  
  2. Effects of weight training on quality of life in recent breast cancer survivors. The Weight Training for Breast Cancer Survivors (WTBS) study. Cancer 2006 published online 27 March. [Medscape]
  3. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 2006; 9: 313-325. [MedNews]
  4. Archives of Internal Medicine  Vol. 166 No. 8, pp. 824-932, April 24, 2006
::::::::::            April 26            ::::::::::      
  1. * Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ (published 10 April 2006)
  2. Bone-patellar tendon-bone autografts versus hamstring autografts for reconstruction of anterior cruciate ligament: meta-analysis. BMJ (published 7 April 2006)
  3. * Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ (published 7 April 2006)
  4. Early determinants of physical activity in adolescence: prospective birth cohort study. BMJ, (published 6 April 2006)
  5. New England Journal of Medicine  Volume 354 April 20, 2006 Number 16
::::::::::            April 25            ::::::::::      
  1. *  The Antimicrobial Treatment Strategies (MIKSTRA) Program: A 5-Year Follow-Up of Infection-Specific Antibiotic Use in Primary Health Care and the Effect of Implementation of Treatment Guidelines. The MIKSTRA Collaborative Study Group. Clin Inf Dis 2006;42:1221-1230. [Eurekalert]
  2. High Rate of Spontaneous Negativity for Hepatitis C Virus RNA after Establishment of Chronic Infection in Alaska Natives. Clin Infect Dis 2006;42:945-954. UpToDate Topic Review: Clinical features and natural history of hepatitis C virus infection. [Medscape]
  3. JAMA Vol. 295 No. 15, pp. 1741-1860, April 19, 2006
::::::::::            April 24            ::::::::::      
  1. Targeting the inflamed synovium: The quest for specificity. Arth & Rheum 2006; 54: 1055-1060. [Eurekalert]
  2. * Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arth & Rheum 2006; 54: 1222-1232. [Eurekalert]
  3. Use of a collagen-platelet rich plasma scaffold to stimulate healing of a central defect in the canine ACL. J Orthopaedic Res 2006; 24: 820-830. [Getting ACL tears to heal themselves- Growth-factor-rich gel regenerates knee ligament, with 40% increase in strength. [Eurekalert]
  4. A randomised controlled trial evaluating the effects of two workstation interventions on upper body pain and incident musculoskeletal disorders among computer operators. Occup Environ Med 2006; 63: 300-306. [Eurekalert]
  5. Annals of Internal Medicine  18 April 2006 Volume 144 Issue 8 Previous Issue
::::::::::            April 21             
  :::::::::  Weekend Reading - Basic Science and general interest articles  ::::::::: 
  1. FDA
    • MedWatch:
      • Macugen (pegaptanib ) Important changes in the approved product labeling. Rare reports of anaphylaxis/anaphylactoid reactions, including angioedema following the administration of Macugen along with various medications administered as part of the injection preparation. [Medscape]
      • Fungal Keratitis Infections Related to Contact Lens Use. Medwatch [Medscape]
      • FDA News: Investigation of Serious Eye Infections Associated With Soft Contact Lens Use and Contact Lens Solution. Consumers Are Advised to Follow Good Hygiene Practices and Manufacturers’ Instructions to Prevent Infection. [Medscape]
    • FDA Safety Changes: Naprosyn/Anaprox and Other Prescription NSAIDs [Medscape]
    • FDA Approvals: Orphan Drug [Medscape]
      • Lestaurtinib (CEP-701 ) for the treatment of acute myeloid leukemia (AML).
      • TRX4 (hAglyCD3) for the treatment of new-onset type 1 diabetes mellitus.
      • EPI-A0001 for the treatment of inherited mitochondrial respiratory chain diseases.
    • Summary View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- January 2006
  2. Hypothalamic huntingtin-associated protein 1 as a mediator of feeding behavior. Nature: Medicine Published online: 9 April 2006.
  3. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nature Medicine 12, 425 - 432 (2006). [Eurekalert: Clues to obesity’s cause ]
  4. * Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome. Science 7 April 2006 312: 117-121. [Eurekalert and Medscape reviews]
    podcastPodcast  suggestion:
    Find out more about podcasting on the iTunes site or see the Wikipedia definition.
::::::::::            April 20            ::::::::::      
  1. Randomized clinical trial comparing surgery with conservative treatment for uncomplicated varicose veins. Br J Surg. 2006; 93(2):175-81 [Medscape review]
  2. Indomethacin and Celecoxib Impair Rotator Cuff Tendon-to-Bone Healing. Am J Sports Med 2006 34: 362-369. [Medscape]
  3. Archives of Internal Medicine Vol. 166 No. 7, pp. 708-812, April 10, 2006
::::::::::            April 19            ::::::::::      
  1. * Initial Results of the Study of Tamoxifen and Raloxifene (STAR) Released: Osteoporosis Drug Raloxifene Shown to be as Effective as Tamoxifen in Preventing Invasive Breast Cancer. NIH News report [Medscape]
  2. New England Journal of Medicine Volume 354 April 13, 2006 Number 15
::::::::::            April 18            ::::::::::      
  1. Epstein-Barr Virus Tied to Multiple Sclerosis in Long-Term Study. Arch Neurol 2006;63:E1-E5.[Medscape]
  2. JAMA Vol. 295 No. 14, pp. 1619-1730, April 12, 2006
::::::::::            April 12            ::::::::::      
  1. Randomized clinical trial comparing surgery with conservative treatment for uncomplicated varicose veins. Br J Surg. 2006; 93(2):175-81 [Medscape review]
  2. Indomethacin and Celecoxib Impair Rotator Cuff Tendon-to-Bone Healing. Am J Sports Med 2006 34: 362-369. [Medscape]
::::::::::            April 11            ::::::::::      
  1. Mitigation strategies for pandemic influenza in the United States. PNAS 2006; published online April 3. [Medscape] [LiveScience animation]
  2. New England Journal of Medicine Volume 354 April 6, 2006 Number 14
::::::::::            April 10            ::::::::::      
  1. ß-Glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations. Am J Clin Nutr 2006;83:601-605. [Medscape]
  2. JAMA Vol. 295 No. 13, pp. 1481-1612, April 5, 2006
    • Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized Trial. The OASIS-6 Trial Group*. JAMA. 2006;295:1519-1530.
    • Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial. Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 (ISAR-REACT 2) Trial Investigators. JAMA. 2006;295:1531-1538.
    • * Effect of 6-Month Calorie Restriction on Biomarkers of Longevity, Metabolic Adaptation, and Oxidative Stress in Overweight Individuals: A Randomized Controlled Trial. Pennington CALERIE Team. JAMA. 2006;295:1539-1548. [Medscape] [NYTimes]
    • * Prevalence of Overweight and Obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555.
    • * Preliminary Communications: Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial. ASTEROID Investigators. JAMA. 2006;295:1556-1565.
    • The Rational Clinical Examination: Can the Clinical History Distinguish Between Organic and Functional Dyspepsia? JAMA. 2006;295:1566-1576.
    • * Editorials: Excessive Adiposity, Calorie Restriction, and Aging. JAMA. 2006;295:1577-1578.
    • Fondaparinux in ST-Segment Elevation Myocardial Infarction: The Drug, the Strategy, the Environment, or All of the Above? JAMA. 2006;295:1579-1580.
    • Clopidogrel Treatment Prior to Percutaneous Coronary Intervention: When Enough Isn't Enough. JAMA. 2006;295:1581-1582.
    • Can a Potent Statin Actually Regress Coronary Atherosclerosis? JAMA. 2006;295:1583-1584.
::::::::::            April 7             
  :::::::::  Weekend Reading - Basic Science and general interest articles  ::::::::: 
  1. FDA
    1. MedWatch: Ontak (denileukin diftitox) warning of the risk for visual loss associated with use. [Medscape]
    2. FDA Approvals: Orphan Drug Approvals: [Medscape]
      • Ceflatonin (homoharringtonine) for the treatment of chronic myeloid leukemia (CML).
      • Valortim ( MDX-1303) for the treatment of anthrax infection.
      • TQ-1018 (topical capsaicin) for the management of postherpetic neuralgia.
    3. The FDA has warned of flagrant violations of donor screening regulations by BioMedical Tissue Services, Inc. which have brought the safety of implanted tissues into question. [Medscape]
  2. Tissue-Engineered Bladders Successfully Implanted Into 7 Patients Needing Cystoplasty [Medscape from April 4 Lancet (limited access)]
  3. Acute Infections May Raise Risk of Venous Thromboembolic Events [Medscape review from Lancet 2006;367:1075-1079. (limited access)]
  4. Religious Attendance: More Cost-Effective Than Lipitor? D. E. Hall. J Am Board Family Med 19:103-109 (2006). [BBC News]
  5. Intellectual ability and cortical development in children and adolescents. Nature 440, 676-679 (30 March 2006) [Brain Development Linked to IQ. ScienceNOW]
  6. Time for the renaissance of medicine in the Middle East. The Lancet 2006; 367:959
::::::::::            April 6             ::::::::::      
  1. News in Cardiology
::::::::::            April 5            ::::::::::      
  1. Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis. Ann Neurol 2006;59:499-503. [Medscape]
  2. Anxiety and stress in the postpartum: is there more to postnatal distress than depression? BMC Psychiatry 2006, 6:12. [Medscape]
  3. Chronic stress at work and the metabolic syndrome: prospective study. BMJ 2006;332:521-525. [Medscape]
  4. Is There Cross-Reactivity Between Penicillins and Cephalosporins? Am J Med 2006 119: 354.
  5. Annals of Internal Medicine 4 April 2006 Volume 144 Issue 7
::::::::::            April 4            ::::::::::      
  1. * Antiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease. Am. J. Respir. Crit. Care Med. 2006; 173: 736-743. [Eurekalert]
  2. Brain Natriuretic Peptide Is a Prognostic Parameter in Chronic Lung Disease. Am. J. Respir. Crit. Care Med. 2006; 173: 744-750. [Eurekalert]
  3. * Novel Endovascular Treatment of Blunt Thoracic Aortic Trauma with a Self-Expanding Stent Lined with Aortic Extender Cuffs. J. K. Thompson, and Others. Annals Vasc Surg 2006; online. [News: Surgeons have developed a new, minimally invasive method for repairing blunt thoracic aortic trauma injuries.]
  4. Archives of Internal Medicine Vol. 166 No. 6, pp. 598-696, March 27, 2006
::::::::::            April 3            ::::::::::      
  1. Infectious Disease News
  2. New England Journal of Medicine   Volume 354 March 30, 2006 Number 13

2006
February March April May June
July
August
September
October
November
December
2005
2004
2003